Neck Cancer

Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity

Why Did Galera Therapeutics Shares Plunge To All Time Lows Today?

Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial

Why Did Galera Therapeutics Shares Plunge To All Time Lows Today?

Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial

Junshi Biosciences, Coherus Receive FDA Breakthrough Therapy Status For Toripalimab In Head & Neck Cancer

Bristol-Myers' Opdvio/Yervoy Combo Therapy Flunks In Head & Neck Cancer Trial

Junshi Biosciences, Coherus Receive FDA Breakthrough Therapy Status For Toripalimab In Head & Neck Cancer

Bristol-Myers' Opdvio/Yervoy Combo Therapy Flunks In Head & Neck Cancer Trial

Galectin Therapeutics Stock Surges After Robust Data From Belapectin/Keytruda Combo In Melanoma, Head & Neck Cancer

Immutep Shares Are Trading Higher On Green Signal To Start Efti Combo Trial In First-Line Head & Neck Cancer

Neck Cancer Recent News

CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients

Vaccinex Initiates Pepinemab Trials for Alzheimer's, Head & Neck Cancer

Nanobiotix's Nanoparticle Technology Shows Tumor-Killing Effect in Early-Stage Head & Neck Cancer

BeiGene's Tislelizumab Shows Progression-Free Survival Benefit in Type Of Head & Neck Cancer

Cue Biopharma's Stock Shoots Up After CUE-101 Shows Promise In Early-Stage Head & Neck Cancer Study

IsoRay's Cesium-131 And Surgical Resection Shows Promise In Recurrent Head & Neck Cancer

Immutep's Lead Candidate To Be Tested In Combination With Keytruda In Second Head & Neck Cancer Study

Immutep (NASDAQ: IMMP)

Kura Oncology Receives FDA Breakthrough Therapy Tag For Tipifarnib In Head & Neck Cancer

Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer